Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

Biogen Idec building

Plegridy approval underlines Biogen Idec’s dominance in MS

And Tecfidera boosts pharma company’s second quarter financial results

- PMLiVE

Two blood cancer drugs among CHMP recommendations

Five new drugs, including Janssen’s Imbruvica and Gilead’s Zydelig, backed for use in Europe

- PMLiVE

Puppet crooner promotes World Hepatitis Day

The World Hepatitis Alliance uses Richard Cheese song to raise awareness

Milestone names chief medical officer

Francis Plat bring experience from Merck, Daiichi-Sankyo, Novartis and BMS to the role

- PMLiVE

Nexavar fails late-stage breast cancer trial

Bayer’s oncology drug unable to improve progression free survival in new indication

dengue fever mosquito

GSK seeks approval for first malaria vaccine

Submits marketing application to European Medicines Agency

- PMLiVE

FDA approves pain drug that has reduced risk of abuse

Purdue’s Targiniq ER developed to deter snorting and injection

- PMLiVE

Neupogen will be first biologic on FDA biosimilars pathway

US regulator will review Novartis’  version of Amgen's Neupogen (filgrastim) over the coming months

Genentech’s Sunil Agarwal joins rare disease firm

He will serve as chief medical officer at Ultragenyx

- PMLiVE

Connelly Partners acquires Mc|K Healthcare

Advertising firm adds healthcare specialist to roster

- PMLiVE

Managing pharma’s uncertainty

Futures we can’t predict need a strategy we can’t plan

- PMLiVE

Turkey aims to become ‘global player’ in biopharma

Government pledges to boost country’s support for medicines access and R&D

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links